BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12661697)

  • 1. Current status of DNA vaccines and their route of administration.
    Alpar HO; Bramwell VW
    Crit Rev Ther Drug Carrier Syst; 2002; 19(4-5):307-83. PubMed ID: 12661697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel vaccine delivery systems: solutions to HIV vaccine dilemmas?
    Sutter G; Haas J
    AIDS; 2001; 15 Suppl 5():S139-45. PubMed ID: 11816162
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical applications of DNA vaccines: current progress.
    Ferraro B; Morrow MP; Hutnick NA; Shin TH; Lucke CE; Weiner DB
    Clin Infect Dis; 2011 Aug; 53(3):296-302. PubMed ID: 21765081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.
    Dietrich G; Spreng S; Favre D; Viret JF; Guzman CA
    Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial ghosts as adjuvant particles.
    Riedmann EM; Kyd JM; Cripps AW; Lubitz W
    Expert Rev Vaccines; 2007 Apr; 6(2):241-53. PubMed ID: 17408373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuated salmonella and Shigella as carriers for DNA vaccines.
    Xu F; Ulmer JB
    J Drug Target; 2003; 11(8-10):481-8. PubMed ID: 15203916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Avian influenza vaccines].
    Vasil'ev IuM
    Vopr Virusol; 2008; 53(6):4-15. PubMed ID: 19172900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Cutaneous Genetic Immunization by Microneedle Array Delivery of an Adjuvanted Adenovirus Vaccine.
    Erdos G; Balmert SC; Carey CD; Falo GD; Patel NA; Zhang J; Gambotto A; Korkmaz E; Falo LD
    J Invest Dermatol; 2020 Dec; 140(12):2528-2531.e2. PubMed ID: 32330464
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic adjuvants for DNA vaccines.
    Scheerlinck JY
    Vaccine; 2001 Mar; 19(17-19):2647-56. PubMed ID: 11257404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microparticles and nanoparticles as delivery systems for DNA vaccines.
    Cui Z; Mumper RJ
    Crit Rev Ther Drug Carrier Syst; 2003; 20(2-3):103-37. PubMed ID: 14584521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties and applications of nanoparticle/microparticle conveyors with adjuvant characteristics suitable for oral vaccination.
    Zhang L; Yang W; Hu C; Wang Q; Wu Y
    Int J Nanomedicine; 2018; 13():2973-2987. PubMed ID: 29861631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity.
    Suschak JJ; Williams JA; Schmaljohn CS
    Hum Vaccin Immunother; 2017 Dec; 13(12):2837-2848. PubMed ID: 28604157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA vaccines--challenges in delivery.
    Pachuk CJ; McCallus DE; Weiner DB; Satishchandran C
    Curr Opin Mol Ther; 2000 Apr; 2(2):188-98. PubMed ID: 11249641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Immunotherapeutics and Vaccine Summit - CHI's fifth annual meeting - novel vaccines: adjuvants and delivery systems: part 2.
    Jones SD
    IDrugs; 2010 Oct; 13(10):692-4. PubMed ID: 20878589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Vaccines, Adjuvants, and Delivery Systems.
    Paston SJ; Brentville VA; Symonds P; Durrant LG
    Front Immunol; 2021; 12():627932. PubMed ID: 33859638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technologies for the design, discovery, formulation and administration of vaccines.
    Ellis RW
    Vaccine; 2001 Mar; 19(17-19):2681-7. PubMed ID: 11257409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon.
    Gupta S; Leutenegger CM; Dean GA; Steckbeck JD; Cole KS; Sparger EE
    J Virol; 2007 Jan; 81(2):465-73. PubMed ID: 17079309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of polyplex-based DNA vaccines.
    Howard KA; Alpar HO
    J Drug Target; 2002 Mar; 10(2):143-51. PubMed ID: 12074541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactococcus lactis-based vaccines: current status and future perspectives.
    Bahey-El-Din M; Gahan CG
    Hum Vaccin; 2011 Jan; 7(1):106-9. PubMed ID: 21263226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on vaccination of cattle and wildlife populations against tuberculosis.
    Buddle BM; Wedlock DN; Denis M; Vordermeier HM; Hewinson RG
    Vet Microbiol; 2011 Jul; 151(1-2):14-22. PubMed ID: 21420804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.